This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.close

Bisphosphonates, and bone anti-resorptive drugs friend or foe? Part 3

Posted on 06 April 2014
Content available to premium subscribers only

This tubules live event aims to:

  • Explore the latest evidence in relation to ostonecrosis of the Jaw
  • Discuss the relevant physiology of the Jaw
  • Explain the benefits and action of bone anti-resorptive drugs
  • Discuss the dental implications of treating patients on anti-resorptive drugs
  • Enable improved risk assessment for dental procedures in our patients

This part 3 of the video. Part 1 is available here, and Part 2 here.

CPD is available in part 3 of the video.

Close